195
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease

, , &
Pages 2747-2755 | Published online: 21 Sep 2020

Figures & data

Figure 1 Study design.

Abbreviations: IL, interleukin; PAS, periodic acid Schiff.
Figure 1 Study design.

Table 1 Phenol Red-Impregnated Thread Wetting Length (mm) in Both Eyes from Baseline to Day 60

Figure 2 Change from baseline in tear production through 60 days of treatment.

Notes: # P <0.05, ## P <0.01 vs cyclosporine ophthalmic emulsion 0.05%; † P <0.05, †† P <0.01, ††† P <0.001 vs NOD diseased control; § P <0.05, §§ P <0.01, §§§ P <0.001 vs placebo.
Abbreviation: NOD, NOD.B10.H2b.
Figure 2 Change from baseline in tear production through 60 days of treatment.

Figure 3 Representative periodic acid Schiff stained conjunctival goblet cells (100x magnification) at day 60.

Abbreviation: NOD, NOD.B10.H2b.

Figure 3 Representative periodic acid Schiff stained conjunctival goblet cells (100x magnification) at day 60.Abbreviation: NOD, NOD.B10.H2b.

Figure 4 Total number of goblet cells in the conjunctiva at day 60.

Notes: †† P <0.01 vs NOD diseased control; §§ P <0.01 vs placebo.
Abbreviations: NOD, NOD.B10.H2b; SD, standard deviation.
Figure 4 Total number of goblet cells in the conjunctiva at day 60.